Evidence map›Paper›PMID 37358642›Full record

ArticleWiener klinische Wochenschrift2023

Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV).

Mattias Mandorfer, Elmar Aigner, Manfred Cejna, Arnulf Ferlitsch, Christian Datz, Tilmann Gräter, Ivo Graziadei, Michael Gschwantler, Stephanie Hametner-Schreil, Harald Hofer and 20 more

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in Wiener klinische Wochenschrift, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Changes in SSM Assessed via 100 Hz-VCTE Are Associated With Acute HVPG-Response to i.v. Propranolol: A European Multicentre Study.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  7. Article
  8. Radiomics-Based Assessment of Portal Hypertension Severity and Risk Stratification of Cirrhotic Patients Using Routine CT Scans.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  9. Article
  10. Prognostication of Liver Disease Patients via the WFUMB 'Rule-of-4' Algorithm Using SSI-2D-SWE-Based Liver Stiffness Measurement.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  11. Non-invasive tests to guide hepatocellular carcinoma surveillance.JHEP reports : innovation in hepatology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. GDF-15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical Outcomes.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 12 institutions in 1 country.

Mattias MandorferDivision of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. mattias.mandorfer@meduniwien.ac.at.ORCID http://orcid.org/0000-0003-2330-0017
Elmar AignerFirst Department of Medicine, Paracelsus Medical University, Salzburg, Austria.
Manfred CejnaDepartment of Radiology, LKH Feldkirch, Feldkirch, Austria.
Arnulf FerlitschDepartment of Internal Medicine I, KH Barmherzige Brüder Wien, Vienna, Austria.
Christian DatzDepartment of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
Tilmann GräterDepartment of Radiology, Medical University of Graz, Graz, Austria.
Ivo GraziadeiDepartment of Internal Medicine, KH Hall in Tirol, Hall, Austria.
Michael GschwantlerDivision of Gastroenterology and Hepatology, Department of Medicine IV, Klinik Ottakring, Vienna, Austria.
Stephanie Hametner-SchreilDepartment of Gastroenterology and Hepatology, Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria.
Harald HoferDepartment of Internal Medicine I, Klinikum Wels-Grieskirchen, Wels, Austria.
Mathias JachsDivision of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Alexander LoizidesDepartment of Radiology, Medical University of Innbsruck, Innsbruck, Austria.
Andreas MaieronDepartment of Internal Medicine II, University Hospital St. Pölten, St. Pölten, Austria.
Markus Peck-RadosavljevicDepartment of Internal Medicine and Gastroenterology, Hepatology, Endocrinology, Rheumatology and Nephrology, Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria.
Florian RainerDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Bernhard ScheinerDivision of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Georg SemmlerDivision of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Lukas ReiderDepartment of Interventional Radiology, Medical University of Vienna, Vienna, Austria.
Silvia ReiterDepartment of Internal Medicine and Gastroenterology and Hepatology, Kepler Universitätsklinikum, Linz, Austria.
Maria SchoderDepartment of Interventional Radiology, Medical University of Vienna, Vienna, Austria.
Rainer SchöflDepartment of Gastroenterology and Hepatology, Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria.
Philipp SchwablDivision of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Vanessa StadlbauerDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Rudolf StauberDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Elisabeth TatscherDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Michael TraunerDivision of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Alexander ZiachehabiDepartment of Internal Medicine and Gastroenterology and Hepatology, Kepler Universitätsklinikum, Linz, Austria.
Heinz ZollerDepartment of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.
Peter FickertDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Thomas ReibergerDivision of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. thomas.reiberger@meduniwien.ac.at.
Medical University of Vienna · ATMedical University of Graz · ATInnsbruck Medical University · ATKepler Universitätsklinikum · ATOrdensklinikum Linz Barmherzige Schwestern · ATParacelsus Medical University · ATHospital of the Brothers of St. John of God · ATKlinikum Klagenfurt · ATKlinikum Wels-Grieskirchen · ATLandeskrankenhaus Feldkirch · ATTirol Kliniken · ATUniversitätsklinikum St. Pölten · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Billroth IV consensus was developed during a consensus meeting of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of Interventional Radiology (ÖGIR) held on the 26th of November 2022 in Vienna.Based on international recommendations and considering recent landmark studies, the Billroth IV consensus provides guidance regarding the diagnosis and management of portal hypertension in advanced chronic liver disease.

Indexed as

Esophageal and Gastric VaricesHypertension, PortalAustriaGastrointestinal HemorrhageHumansLiver CirrhosisAcute-on-chronic liver failureAscitesCirrhosisElastographyHepatorenal syndromeHVPGPortal vein thrombosisSpontaneous bacterial peritonitisTransjugular intrahepatic portosystemic shuntVariceal bleedingVarices

Identifiers

PMID37358642
PMCPMC10319704
OpenAlexW4382010689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.